Search Details

Word: developed (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...future years, we are going to develop more data from employers,” Inca said...

Author: By Evan H. Jacobs, CONTRIBUTING WRITER | Title: Harvard Ranked Top in World | 11/8/2004 | See Source »

...score seemed to ease the nerves of an eager Crimson team—especially Vaillancourt—and the team settled into an offensive rhythm that dictated play and waited for opportunities to develop...

Author: By Jonathan Lehman, CONTRIBUTING WRITER | Title: W. Hockey Takes Two on Regular Season’s Opening Weekend | 11/8/2004 | See Source »

...beginning of this fall season, there were two things everyone in TV knew: 1) the key to success was to develop shows that were as much like CSI as possible, and 2) ABC was deep in the ratings toilet. The alphabet network finished last season in fourth place, without a major hit sitcom or drama or, above all, a big crime franchise...

Author: /time Magazine | Title: Television: Counter-Procedural: Attack of the Killer Serials | 11/8/2004 | See Source »

...keep acid-reflux disease in check. But a study in the Journal of the American Medical Association says they may put you at risk for pneumonia. Dutch researchers studied more than 360,000 patients and found that users of the powerful acid-fighting drugs were 89% more likely to develop pneumonia than people who no longer took them. Less potent acid reducers such as Pepcid and Tagamet also raised the risk of pneumonia, by 63%. Doctors say such drugs are so good at knocking out the stomach's germ-killing acids that they make patients--especially the elderly and people...

Author: /time Magazine | Title: Health: Side Effect: Pneumonia? | 11/8/2004 | See Source »

...Johnson felt much the same way in the mid-1990s about its new business selling stents, the tiny devices used to prop open clogged arteries. With a virtual monopoly of the billion-dollar business, J&J alienated many of its cardiologist customers by charging high prices and failing to develop a new generation of product. When competitors like Guidant and Boston Scientific came out with their own stents, customers were eager to abandon J&J (which has admitted being slow to innovate but denies that its pricing was at fault). Says Sydney Finkelstein, a professor at Dartmouth's Tuck business...

Author: /time Magazine | Title: Management: After The Flood | 11/8/2004 | See Source »

Previous | 498 | 499 | 500 | 501 | 502 | 503 | 504 | 505 | 506 | 507 | 508 | 509 | 510 | 511 | 512 | 513 | 514 | 515 | 516 | 517 | 518 | Next